📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Update on risankizumab for the treatment of moderate to severe psoriasis. (2020)

First Author: Al-Janabi A

Attributed to: MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14712598.2020.1822813

PubMed Identifier: 32933320

Publication URI: http://europepmc.org/abstract/MED/32933320

Type: Journal Article/Review

Volume: 20

Parent Publication: Expert opinion on biological therapy

Issue: 11

ISSN: 1471-2598